Your browser doesn't support javascript.
loading
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment.
Lee, Cheol-Hyung; Lee, Yun Bin; Kim, Minseok Albert; Jang, Heejoon; Oh, Hyunwoo; Kim, Sun Woong; Cho, Eun Ju; Lee, Kyung-Hun; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Kim, Tae-You; Kim, Yoon Jun.
Afiliación
  • Lee CH; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lee YB; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim MA; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Jang H; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Oh H; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim SW; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Cho EJ; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lee KH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Lee JH; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Yu SJ; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Yoon JH; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim TY; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Clin Mol Hepatol ; 26(3): 328-339, 2020 07.
Article en En | MEDLINE | ID: mdl-32460459
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Piridinas / Carcinoma Hepatocelular / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Mol Hepatol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Piridinas / Carcinoma Hepatocelular / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Mol Hepatol Año: 2020 Tipo del documento: Article